Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiawei Wu
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0008-1770-2574
Observed ORCID:
0009-0008-1770-2574
OpenAlex ID:
A5137575806
Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
·
Cancer Research
·
1
Supplementary Figure S3 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Data from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S6 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Figure S5 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Figure S4 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Figure S7 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Figure S2 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S4 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Figure S6 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S7 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S8 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S2 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S1 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Figure S1 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S5 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Table S3 from MYO1G Facilitates Caveolin 1–Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy
2026
·
Cong Ding
, Jiawei Wu
, et al.
Supplementary Figure S4 from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Supplementary Figure S3 from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Supplementary Figure S6 from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Supplementary Figure S5 from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Supplementary Figure S1 from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Data from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Supplementary Figure S2 from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Supplemental Tables from Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity
2026
·
Zhenji Deng
, Chuqing Zhang
, et al.
Show more works
View as search
Works count:
25
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type